Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph P Colgan

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Echo Research and Practice|July 15, 2018
A male with multiple cardiac massesManasawee Indrabhinduwat, Maria C Arciniegas Calle, Joseph P Colgan, et al.
Multiple Sclerosis and Related Disorders|December 1, 2017
A Case of cutaneous large B-cell lymphoma during treatment of multiple sclerosis with fingolimodDerek W Stitt, Christopher J Boes, Eoin P Flanagan, et al.
The American Journal of Surgical Pathology|June 17, 2011
A case of hairy cell leukemia with CCND1-IGH@ translocation: indolent non-nodal mantle cell lymphoma revisitedDong Chen, Rhett P Ketterling, Curtis A Hanson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2005
Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphomaWilliam G Martin, Kay M Ristow, Thomas M Habermann, et al.
Journal of the American Academy of Dermatology|April 25, 2009
Unusual cutaneous manifestations of B-cell chronic lymphocytic leukemiaJose Antonio Plaza, Nneka I Comfere, Lawrence E Gibson, et al.
Cancer|May 26, 2004
High-dose intravenous methotrexate followed by autologous stem cell transplantation as a potentially effective therapy for neurolymphomatosisIrene M Ghobrial, Francis Buadi, Robert J Spinner, et al.
The Lancet. Haematology|July 5, 2016
Everolimus combined with R-CHOP-21 for new, untreated, diffuse large B-cell lymphoma (NCCTG 1085 [Alliance]): safety and efficacy results of a phase 1 and feasibility trialPatrick B Johnston, Betsy LaPlant, Ellen McPhail, et al.
Cancer|November 14, 2006
A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphomaIvana N M Micallef, Brad S Kahl, Matthew J Maurer, et al.
Leukemia & Lymphoma|July 7, 2007
Effectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell lymphoma not responding to cis-platinum, cytosine arabinoside, and dexamethasoneLijo Simpson, Stephen M Ansell, Joseph P Colgan, et al.
Haematologica|October 14, 2011
Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphomaLuis F Porrata, Kay Ristow, Joseph P Colgan, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Echo Research and Practice|July 15, 2018
A male with multiple cardiac massesManasawee Indrabhinduwat, Maria C Arciniegas Calle, Joseph P Colgan, et al.
Multiple Sclerosis and Related Disorders|December 1, 2017
A Case of cutaneous large B-cell lymphoma during treatment of multiple sclerosis with fingolimodDerek W Stitt, Christopher J Boes, Eoin P Flanagan, et al.
The American Journal of Surgical Pathology|June 17, 2011
A case of hairy cell leukemia with CCND1-IGH@ translocation: indolent non-nodal mantle cell lymphoma revisitedDong Chen, Rhett P Ketterling, Curtis A Hanson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2005
Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphomaWilliam G Martin, Kay M Ristow, Thomas M Habermann, et al.
Journal of the American Academy of Dermatology|April 25, 2009
Unusual cutaneous manifestations of B-cell chronic lymphocytic leukemiaJose Antonio Plaza, Nneka I Comfere, Lawrence E Gibson, et al.
Cancer|May 26, 2004
High-dose intravenous methotrexate followed by autologous stem cell transplantation as a potentially effective therapy for neurolymphomatosisIrene M Ghobrial, Francis Buadi, Robert J Spinner, et al.
The Lancet. Haematology|July 5, 2016
Everolimus combined with R-CHOP-21 for new, untreated, diffuse large B-cell lymphoma (NCCTG 1085 [Alliance]): safety and efficacy results of a phase 1 and feasibility trialPatrick B Johnston, Betsy LaPlant, Ellen McPhail, et al.
Cancer|November 14, 2006
A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphomaIvana N M Micallef, Brad S Kahl, Matthew J Maurer, et al.
Leukemia & Lymphoma|July 7, 2007
Effectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell lymphoma not responding to cis-platinum, cytosine arabinoside, and dexamethasoneLijo Simpson, Stephen M Ansell, Joseph P Colgan, et al.
Haematologica|October 14, 2011
Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphomaLuis F Porrata, Kay Ristow, Joseph P Colgan, et al.
Pageof 4